Invention Grant
- Patent Title: Transgenic plants expressing cobalamin binding proteins
-
Application No.: US12357622Application Date: 2009-01-22
-
Publication No.: US09751918B2Publication Date: 2017-09-05
- Inventor: Lars Erik Berglund , Torben Ellebaek Petersen , Sergey Nikolaevich Fedosov , Ebba Nexo , Niels Bech Laursen , Erik Ostergaard Jensen
- Applicant: Lars Erik Berglund , Torben Ellebaek Petersen , Sergey Nikolaevich Fedosov , Ebba Nexo , Niels Bech Laursen , Erik Ostergaard Jensen
- Applicant Address: US MO St. Louis
- Assignee: XERAGENX LLC
- Current Assignee: XERAGENX LLC
- Current Assignee Address: US MO St. Louis
- Priority: GB0117171.9 20010713
- Main IPC: C07K14/47
- IPC: C07K14/47 ; C12N15/82 ; A61K31/7056 ; A61K38/16 ; A61K47/48 ; C07K14/415 ; C12N5/071 ; A61K38/00
Abstract:
The present invention relates to the use of transgenic plants for the expression of vitamin B12 (cobalamin) binding proteins. Plant cells are transformed with nucleotide sequences adapted for expression and secretion of vitamin B12 binding proteins. The present invention also relates to the use of recombinant vitamin B12 binding proteins from plants in analytical tests and treatment of vitamin B12 deficiency. Also disclosed is a method for purification of recombinant vitamin B12 binding proteins.
Public/Granted literature
- US20100184642A1 Transgenic Plants Expressing Cobalamin Binding Proteins Public/Granted day:2010-07-22
Information query
